A combination therapy of at least one FBPase inhibitor and at least one other antidiabetic agent is disclosed.

 
Web www.patentalert.com

< Asthma preparation

> 2-methylene-19-nor-(20S-24S)-1.alpha.,25-dihydroxyvitamin-D.sub.2

> Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents
~ 00534